Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily

Elad Moisseiev, Shimon Kurtz, Moshe Lazar, Gabi ShemeshDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelBackground: The purpose of this study was to evaluate the safety and efficacy of a fixed combination of timolol maleate 0.5% + brimonidine tartrate 0.2% (Combigan&...

Full description

Saved in:
Bibliographic Details
Main Authors: Moisseiev E, Kurtz S, Lazar M, Shemesh G
Format: article
Language:EN
Published: Dove Medical Press 2013
Subjects:
Online Access:https://doaj.org/article/d7dfd0561d86498b9fa3237127e0105b
Tags: Add Tag
No Tags, Be the first to tag this record!